Clinical Trial: DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer

Brief Summary: Palliative radiotherapy for head and neck cancer is widely used but the effect and side effects are largely unknown. We will study the effect of short hypofractionated palliative radiotherapy (20 Gy in 4 fractions) on symptom intensity and -frequency as weel as side effects

Detailed Summary:
Sponsor: University of Aarhus

Current Primary Outcome: Frequency and intensity of symptoms before and after radiotherapy (EORTC C30 and H&N35 questionnaires and CTC AE 3.0 toxicity scores) [ Time Frame: 11 mths ]

Original Primary Outcome: Frequency and intensity of symptoms before and after radiotherapy (EORTC C30 and H&N35 questionnaires and CTC AE 3.0 toxicity scores)

Current Secondary Outcome:

  • Survival [ Time Frame: 11 mths ]
  • Side effects [ Time Frame: 2 mths ]
  • Other treatments [ Time Frame: 11 mths ]


Original Secondary Outcome:

  • Survival
  • Side effects
  • Other treatments


Information By: University of Aarhus

Dates:
Date Received: November 15, 2006
Date Started: November 2006
Date Completion:
Last Updated: June 18, 2013
Last Verified: June 2013